A PBPK Model to Predict Disposition of CYP3A‐Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Besides logistical and ethical concerns, evaluation of safety and efficacy of medications in pregnant women is complicated by marked changes in pharmacokinetics (PK) of drugs. For example, CYP3A activity is induced during the third trimester (T 3). We explored whether a previously published physiologically based pharmacokinetic (PBPK) model could quantitatively predict PK profiles of CYP3A‐metabolized drugs during T 3, and discern the site of CYP3A induction (i.e., liver, intestine, or both). The model accounted for gestational age‐dependent changes in maternal physiological function and hepatic CYP3A activity. For model verification, mean plasma area under the curve (AUC), peak plasma concentration (Cmax), and trough plasma concentration (Cmin) of midazolam (MDZ), nifedipine (NIF), and indinavir (IDV) were predicted and compared with published studies. The PBPK model successfully predicted MDZ, NIF, and IDV disposition during T 3. A sensitivity analysis suggested that CYP3A induction in T 3 is most likely hepatic and not intestinal. Our PBPK model is a useful tool to evaluate different dosing regimens during T 3 for drugs cleared primarily via CYP3A metabolism. CPT: Pharmacometrics & Systems Pharmacology(2012) 1, e3; doi:10.1038/psp.2012.2; advance online publication 26 September 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371
Self-citation
Cited by
Sager, J. E., Yu, J., Ragueneau-Majlessi, I., & Isoherranen, N. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065920 · Cited by 518
Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050245 · Cited by 239
“This has been done, for example, to model the increase in CYP3A4 activity during pregnancy (Ke et al., 2012), and the results have profound implications to the dosage determination and efficacy of many CYP3A4 substrates during pregnancy, including many of the human immunodeficiency virus protease inhibitors (Roustit e…”
BackgroundLin, W., Chen, Y., Unadkat, J. D., Zhang, X., Wu, D., & Heimbach, T. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03274-2 · Cited by 137
Self-citationCPT: Pharmacometrics and Systems Pharmacology
van der Graaf, P. H. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.8 · Cited by 100
Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence
Rostami‐Hodjegan, A. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.904 · Cited by 90
Self-citation
Metadata
- Authors
- Ke, A., Nallani, S., Zhao, P., Rostami‐Hodjegan, A., & Unadkat, J.
- Venue
- CPT: Pharmacometrics & Systems Pharmacology
- Publisher
- Wiley
- Published
- 2012-09
- Volume
- 1
- Issue
- 9
- Pages
- 1-10
- ISSN
- 2163-8306 (ISSN-L)
- OpenAlex
- W2079760663
- Cited by
- 93
- References
- 1
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.